Tamarly Intelligence
Private raises · SEC Form D

Rgenta Therapeutics, Inc.: $42 million Raised, SEC Form D Filings

Rgenta Therapeutics, Inc., a private technology company in Woburn, Massachusetts, reported $42 million sold in a Form D filed 3 November 2026.

Company · Other Technology · MA · SEC CIK 1801266 · Company page

Share this pageLinkedInXEmail

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
3 Nov 2026New notice$130 million$42 millionOther TechnologyForm D

Questions and answers

How much has Rgenta Therapeutics, Inc. raised?
Rgenta Therapeutics, Inc. reported $42 million sold in its largest Form D notice on file; its latest notice was filed on 3 November 2026. Form D amounts are what the issuer reported to the SEC.
What is Rgenta Therapeutics, Inc.?
Rgenta Therapeutics, Inc. is a company in other technology, based in Woburn, Massachusetts, according to its SEC Form D filings.
How many Form D notices has Rgenta Therapeutics, Inc. filed?
1 notice between 3 November 2026 and 3 November 2026 in Tamarly's record, which starts on 1 October 2025.
Get an email when Rgenta Therapeutics, Inc. files again
No account needed. Choose one:
See every Form D raise as it arrives, free and with no account.Explore for free

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "Rgenta Therapeutics, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/1801266, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.